Form 4 for PG Procter & Gamble
Accepted 2022-10-04 00:00:00 ET · period of report 2022-10-03 · accession 0001127602-22-023552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-04 | 2022-10-03 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +6,746 | 39.6K | +21% | $0 |
| D | 2022-10-04 | 2022-10-03 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +29.2K | 29.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-03 | A | A | 6,746 | $0.00 | 39,640.79 | D | — | — | (F1) Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-10-03 | A | A | 29,198 | $0.00 | 29,198 | D | $128.51 · 2025-10-01 to 2032-10-01 | 29,198 Common Stock |